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 Currently, most in vitro drug release studies for ophthalmic applications are 
carried out in static sink conditions. Although this procedure is simple and 
useful to make comparative studies, it does not describe adequately the drug 
release kinetics in the eye, considering the small tear volume and flow rates 
found in vivo. 
In a normal situation, the human eye contains a tear volume that ranges from 
6.2 to 30.0 L [1] and the tear flow rate assumes values between 0.9 and 2.1 
L/min [2]. The use of contact lenses increases the tear turnover to values of 
the order 1.4-4.3 L/min [2]. 
Introduction 
 Microfluidic cell (MFC)  
A MFC of poly(methylmethacrylate) with a cylindrical inner chamber of 45 µL  
was designed and fabricated. 
  
 
 
 
 
 
The flow inside the microfluidic cell was modeled through the numerical solution 
of the Navier-Stokes and continuity equations using the Star-CCM+ simulation 
package. 
 Drug release experiments 
- Static: Diclofenac loaded 2-hydroxyethyl methacrylate  (PHEMA) samples 
were immersed in 4 mL of PBS solution in closed vessels, at 36 °C, under 
stirring (180 rpm). At predetermined time intervals, 800 µl aliquots of the 
supernatant were collected and replaced by the same volume of fresh PBS 
solution.  
- Dynamic: drug release experiments in the microfluidic cell were performed at 
36°C and a continuous flow of PBS of 3 µL/min. 
 In vivo efficacy 
The in vivo efficacy of anti-inflammatory released in dynamic conditions was 
estimated through comparison to the daily dose delivered by topical application. 
Methods 
Results 
 A microfluidic cell was successfully fabricated to approximate in vitro ocular drug release 
experiments to the eye tear film in vivo hydrodynamic conditions. 
 Experimental results shown that DCF release kinetics is affected by the release 
conditions; dynamic conditions developed in this study are expected to be closer to the in 
vivo conditions when compared with common sink conditions. 
 Results suggest the studied drug/hydrogel pair shall be effective during  5 days.  
Conclusions 
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i) Design and validation of a microfluidic cell to mimic the 
continuous, volumetric flow rate of tear fluid and its low volume; 
ii) Comparison of drug release profiles of anti-inflammatory, diclofenac 
(DCF), from a soft contact lens material obtained in static sink and in 
dynamic conditions; 
iii) Estimation of the drug released in vivo efficacy. 
Objectives 
Figure 1.  
a) Schematic design of 
the MFC 
b) Experimental 
apparatus 
Figure 4.  DCF concentration 
Day 
DCF mass 
(µg/lens) 
1 420.0 
2 127.7 
3 54.0 
4 22.8 
5 9.7 
6 3.6 
Table 1. Amount of DCF released 
from PHEMA , estimated by 
numerical simulation 
 MFC inner chamber with volume of 45 µL. 
 Considering a flow rate of 3µL/min, the fluid flows in the cell 
uniformly (Figure 2). Symmetric and very regular paths are 
followed from the inlet pipe to the eight exiting pipes. 
 Possibility of numerically simulate other inner chamber 
volumes and flow rates. Figure 2. Representation of the fluid 
paths inside the microfluidic cell 
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Figure 3.  DCF fractional cumulative mass release 
 Different release kinetics for the same drug/hydrogel pair. 
. 3 mL 
. 45 µL 
. Continuous flow 
 From the release results in dynamic conditions it is possible to estimate the concentration of 
DCF released from PHEMA hydrogels in a volume equivalent to the tear film. 
Considering that…. 
The recommend posology for DCF is 8.5 µg/day (5 x 1 drop). 
 Results suggest the studied drug/hydrogel pair shall be effective during  5 days.  
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  In order to predict in a more reliable way the drug 
release kinetics in the eye, it is crucial to develop 
microfluidic models that mimic, as close as possible, 
the hydrodynamic conditions of the eye.  
